Table 2.
Low dose N = 100 |
Normal dose [14] N = 17 |
P value | |
---|---|---|---|
Exposure parameters | |||
Tube voltage 3DRA (kV) | 70 (60–96) | 90 (90–90) | < 0.001 |
Tube current 3DRA (mA) | 228 (53–395) | 69 (26–363) | < 0.001 |
Exposure time 3DRA (ms) | 465.5 (333.2–1330) | 843.2 (452.2–868) | < 0.001 |
Skin dose 3DRA (mGy) | 9 (1.7–83) | 20,86 (10,33–90,69) | < 0.001 |
DAP 3DRA (mGy·cm2) | 1279 (150–16,987) | 3128 (1231–17,273) | < 0.001 |
Procedural time (min) | 153 (30–360) | 165 (60–540) | 0.360 |
Total fluoroscopy time (min) | 28 (0.4–121) | 22 (6.4–81.4) | 0.497 |
Effective dose | |||
3DRA (mSv) | 0.54 (0.12–2.23) | 1.62 (0.70–4.94) | < 0.001 |
Fluoroscopy (mSv) | 1.53 (0.00–25.40) | 4.4 (0.2–15.8) | 0.002 |
Angiography (mSv) | 0.45 (0.00–19.33) | 3.6 (0–79.1) | 0.009 |
Total catheterization (mSv) | 2.64 (0.27–28.13) | 12.4 (2–99.9) | < 0.001 |
Interventional group | 3.65 (0.49–28.13) | ||
Diagnostic group | 0.86 (0.27–10.09) |
Values represent median and range